What is the significance of elevated 17-hydroxyprogesterone (17-HP) and elevated Dehydroepiandrosterone sulfate (DHEA-S)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis for Elevated 17 Hydroxyprogesterone and DHEA Sulfate

Single Most Likely Diagnosis

  • Congenital Adrenal Hyperplasia (CAH) due to 21-Hydroxylase Deficiency: This condition is the most common cause of elevated 17 hydroxyprogesterone and often presents with elevated DHEA sulfate levels. It results from a deficiency in the enzyme 21-hydroxylase, leading to an accumulation of precursors such as 17 hydroxyprogesterone.

Other Likely Diagnoses

  • Adrenal Tumor or Hyperplasia: Adrenal tumors or hyperplasia can lead to the overproduction of various adrenal hormones, including DHEA sulfate and 17 hydroxyprogesterone. The clinical presentation can vary depending on the type of tumor or the extent of hyperplasia.
  • Prolonged ACTH Stimulation: Prolonged stimulation of the adrenal glands by adrenocorticotropic hormone (ACTH) can lead to increased production of adrenal hormones, including 17 hydroxyprogesterone and DHEA sulfate. This could be due to various causes, including Cushing's disease or exogenous ACTH administration.

Do Not Miss Diagnoses

  • Cushing's Syndrome: Although less likely to present with significantly elevated 17 hydroxyprogesterone, Cushing's syndrome due to an adrenal source (e.g., adrenal adenoma or carcinoma) could potentially cause an elevation in DHEA sulfate. Missing this diagnosis could lead to significant morbidity and mortality due to uncontrolled glucocorticoid excess.
  • Adrenocortical Carcinoma: A rare but potentially deadly diagnosis, adrenocortical carcinoma can produce a variety of adrenal hormones, leading to elevated levels of 17 hydroxyprogesterone and DHEA sulfate among other hormones. Early detection is crucial for treatment and prognosis.

Rare Diagnoses

  • 3-Beta-Hydroxysteroid Dehydrogenase Deficiency: A rare form of congenital adrenal hyperplasia, this deficiency affects the conversion of pregnenolone to progesterone and 17-hydroxypregnenolone to 17-hydroxyprogesterone, potentially leading to elevated levels of 17 hydroxyprogesterone and DHEA sulfate.
  • 11-Beta-Hydroxylase Deficiency: Another rare form of CAH, this deficiency can lead to an overproduction of androgens, including DHEA sulfate, and can also affect the production of 17 hydroxyprogesterone, although the pattern of elevation might differ from that seen in 21-hydroxylase deficiency.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.